America Votes, China Plans
By James Strachan
November 3, 2026
China sets out its stall for global biopharmaceutical preeminence as the US faces further uncertainty over research funding and regulation
23 min read
False
By James Strachan
November 3, 2026
China sets out its stall for global biopharmaceutical preeminence as the US faces further uncertainty over research funding and regulation
23 min read
By Mouj Hijazi
October 20, 2026
Regeneron Genetics Center’s Luca Lotta explains how population-scale genetic evidence can reveal more promising drug targets and open new possibilities for disease prevention
4 min read
October 20, 2026
Piers Ingram discusses the resurgence of immunology, engineering-led drug discovery, and how artificial intelligence can shape the next generation of medicines
4 min read
October 15, 2026
Advances in translational science are helping researchers better understand psychiatric disease biology, says Tanya Wallace
8 min read
By Ali Tavassoli
September 10, 2026
Ali Tavassoli explains how cyclic peptides and new discovery tools are opening up once-inaccessible biology
8 min read
By Miguel Forte
September 8, 2026
Scientific progress alone isn't enough, says Miguel Forte, who argues that reimbursement and patient access will shape the next decade of cell and gene therapy
4 min read
September 4, 2026
Peng Lu argues that small molecules remain indispensable as AI transforms drug development
2 min read
September 2, 2026
Glycosylation could offer cancer researchers a new way to understand tumors, identify biomarkers, and develop more precise therapies
3 min read
August 26, 2026
Merck and Moderna report positive phase III results for intismeran in melanoma, as The Medicine Maker revisits how cancer vaccines work and the challenges still facing the field
7 min read
By Andrea Jacobs
August 25, 2026
Reliable discovery insights depend on models grounded in curated, verifiable scientific knowledge
5 min read
False
False
False
Affiliations:
Specialties:
Areas of Expertise: